zidovudine ( azt , 3'-azido-3'-deoxythymidine ) was shown in a controlled trial to decrease the incidence of mortality , reduce the frequency of opportunistic infections , and provide other clinical benefits to patients with acquired immune deficiency syndrome ( aids ) and advanced aids-related complex .
C0043474
3
C0001175
aids